Should Investors Buy, Sell or Hold Lilly Stock Ahead of Q4 Earnings?Zacks Investment Research • 02/02/26
Eli Lilly CEO says Medicare coverage of obesity drugs could 'change the game' for upcoming pill launchCNBC • 01/30/26
Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injectionsCNBC • 01/30/26
Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facilityPRNewsWire • 01/30/26
Unveiling Lilly (LLY) Q4 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 01/30/26
FDA Decision on Eli Lilly's Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?The Motley Fool • 01/30/26
Eli Lilly Teams Up With Two Biotechs To Target Autoimmune Disease, Hearing Loss In Deals Worth $3 BillionBenzinga • 01/29/26
Prediction: Artificial Intelligence (AI) Will Reshape This Industry by 2030. This Stock Could Lead.The Motley Fool • 01/29/26
Eli Lilly partners with Seamless Therapeutics on gene editing treatments for hearing lossProactive Investors • 01/28/26
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 01/28/26
Exclusive: Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data showsReuters • 01/28/26